Eli Lilly Drug Maintains Lean Mass During Weight Loss with Wegovy

1 min read
Source: STAT
Eli Lilly Drug Maintains Lean Mass During Weight Loss with Wegovy
Photo: STAT
TL;DR Summary

A Phase 2 trial shows that combining Eli Lilly's bimagrumab with Wegovy results in greater weight loss, primarily from fat, and better preservation of lean mass compared to Wegovy alone, with significant reductions in harmful visceral fat.

Share this article

Reading Insights

Total Reads

0

Unique Readers

1

Time Saved

1 min

vs 1 min read

Condensed

80%

18737 words

Want the full story? Read the original article

Read on STAT